Title: Hoeflich KP, et al. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 2012 Jan 1;72(1):210-9.
1369665-02-0
934665-56-2
934663-52-2
915924-63-9 | N-[(5-Methyl-1,2,4-oxadiazol-3-yl)methyl]propan-2-amine hydrochloride | AA00GTOK | MFCD08691561
90151-46-5 | 1-(3-Bromophenyl)ethanamine, HCl | AA00GTUL | MFCD26960538
91713-54-1 | (2-Amino-5-methoxyphenyl)(4-chlorophenyl)methanone | AA00GU1F | MFCD20568256
915191-42-3 | MF498 | AA00GU6B | MFCD17166964
923226-69-1 | 1-((2-Fluorophenyl)carbamoyl)piperidine-3-carboxylic acid | AA00GUA4 | MFCD08444821
879319-18-3 | 2-CHLORO-N-(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)-N-ETHYLPROPANAMIDE | AA00GUDG | MFCD08261046
886209-47-8 | N-(3-Aminopropyl)maleimide trifluoroacetate salt | AA00GULF | MFCD11519189
914637-40-4 | 3-Chloro-6-methylpyridazine-4-carboxylic acid | AA00GUTO | MFCD08235214
91990-88-4 | 4-Benzoylbenzoic acid succinimidyl ester | AA00GV6F | MFCD00058572
915920-25-1 | 2-(3-Methylpiperidin-1-yl)propanoic acid | AA00GVE5 | MFCD08691674